Grace Therapeutics, Inc. - Common Stock (NQ:GRCE)

2.938 +0.118 (+4.18%)

Streaming Delayed Price Updated: 2:00 PM EDT, Jun 4, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	17,113
Open	2.800
Bid (Size)	2.910 (10)
Ask (Size)	2.990 (24)
Prev. Close	2.820
Today's Range	2.800 - 2.990
52wk Range	1.750 - 4.965
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

March 11, 2025

From Matinas BioPharma Holdings, Inc.

Via GlobeNewswire

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study

February 10, 2025

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.

Via Benzinga

Performance

YTD	-26.5%	-26.5%
1 Month	+17.3%	+17.3%
3 Month	-4.0%	-4.0%
6 Month	-14.6%	-14.6%
1 Year	-8.5%	-8.5%

Frequently Asked Questions

Is Grace Therapeutics, Inc. - Common Stock publicly traded?

Yes, Grace Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Grace Therapeutics, Inc. - Common Stock trade on?

Grace Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Grace Therapeutics, Inc. - Common Stock?

The ticker symbol for Grace Therapeutics, Inc. - Common Stock is GRCE on the Nasdaq Stock Market

What is the current price of Grace Therapeutics, Inc. - Common Stock?

The current price of Grace Therapeutics, Inc. - Common Stock is 2.938

When was Grace Therapeutics, Inc. - Common Stock last traded?

The last trade of Grace Therapeutics, Inc. - Common Stock was at 06/04/25 02:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.